Financial News
Regeneron to request FDA clearance to use Covid antibody drug as a preventative treatment
April 12, 2021 at 01:00 AM EDT
Regeneron said a phase three clinical trial of the drug reduced the risk of symptomatic infections in individuals by 81%.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
